Aridis Pharmaceuticals Inc Stock Ownership - Who owns Aridis Pharmaceuticals?

Insider buying vs selling

Have Aridis Pharmaceuticals Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ARDS insiders and whales buy or sell their stock.

ARDS Shareholders

What type of owners hold Aridis Pharmaceuticals Inc stock?
Fibrosis Foundation Cystic24.84%5,168,732$1.92MInsider
Armistice Capital LLC9.94%2,068,000$769.30kInstitution
Vu Truong3.54%737,353$274.30kInsider
Eric Patzer3.37%702,132$261.19kInsider
Commonwealth Equity Services LLC2.76%575,000$213.90kInstitution
Vanguard Group Inc2.52%524,453$195.10kInstitution
Roumell Asset Management LLC2.15%446,588$166.13kInstitution
Geode Capital Management LLC0.69%143,034$53.21kInstitution
State Street Corp0.21%43,247$16.09kInstitution
Northern Trust Corp0.14%28,104$10.45kInstitution

1 of 3

ARDS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AYTU21.24%78.76%Net Buying
TMBR0.12%99.88%Net Buying
GLS15.18%48.57%Net Buying

Aridis Pharmaceuticals Stock Ownership FAQ

Who owns Aridis Pharmaceuticals?

Aridis Pharmaceuticals (NASDAQ: ARDS) is owned by 18.67% institutional shareholders, 31.80% Aridis Pharmaceuticals insiders, and 49.54% retail investors. Fibrosis Foundation Cystic is the largest individual Aridis Pharmaceuticals shareholder, owning 5.17M shares representing 24.84% of the company. Fibrosis Foundation Cystic's Aridis Pharmaceuticals shares are currently valued at $1.92M.

If you're new to stock investing, here's how to buy Aridis Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.